After 12 weeks, the researchers noted the following weight changes in the two groups: [table id=356 /] The following blood work changes were also found in the two groups: [table id=357 /] For the researchers, 12 weeks of carnitine administration in women with polycystic ovary syndrome resulted in reductions in weight, body mass index, weight circumference, and hip circumference, and beneficial effects on blood sugar control though they admit that Further long-term studies with higher doses of carnitine are needed to examine the effect of carnitine supplementation on markers of insulin resistance, lipid profiles and hormonal outcomes in polycystic ovary syndrome patients. * HOMA RI is used as a screening test for glucose intolerance
Source Reference: Kellner DA, et al "Effect of glucagon-like peptide 1 receptor agonists on patients with rheumatoid arthritis" ACR Open Rheumatol 2025
Interest is real, but the responsible approach is not to treat it as a shortcut
This is the point where the bacterial strains should be well established, metabolite production should be consistent, and the downstream effects on GLP-1 should be at their peak
Citation: Markovic J, Mora NJ, Broseta AM, Gimeno A, de-la-Concepcin N, Via J, et al
Over the past few decades, despite numerous positive reports on antioxidant therapy, its efficacy in treating neurodegenerative diseases is a subject of controversy for several reasons
